Field Safety Notice Olympus UHI-4 High Flow Insufflation Unit (ICN 2375)
Important Customer Notice Field Safety Notice
Ref: 2023/2375
ICN Number: 2375
Alert:
- Olympus has released a Field Safety Notice relating to UHI-4 High Flow Insufflation Unit products.
- There are three product codes affected.
- Olympus has become aware of patients experiencing complications from over-insufflation where UHI-4s were used. Clinical complications cited from Olympus include “short cardiac arrest gas embolism and one death during surgical procedures where the UHI-4 has been used.
- These complications may have been due to over-insufflation of the abdominal cavity resulting from the use of the UHI-4 during the procedures. This includes events where the device was reported to not alarm or otherwise notify the user and events where the device did not relieve the over-insufflation to the set pressure.
Products Affected:
- The affected products are not available via the NHS Supply Chain catalogue.
- These capital products are purchased via OJEU (Official Journal of the European Union) compliant orders using our Unique Reference Number (URN) requested from the buying team.
Material ID | Model | Description | UDI | Serial Numbers |
N3829650 | UHI-4 | Insufflator, UHI-4, 220-240V | 04953170435881 | All |
N3829660 | UHI-4 | Insufflator, UHI-4, 220-240V | 04953170324154 | All |
N3829670 | UHI-4 | Insufflator, UHI-4, 220-240V | 04953170324161 | All |
Next Steps
- See our Downloads ▼ section to access the full instructions in the Field Safety Notice and share them with all users of the affected products.
- Follow local organisational risk assessment.
- You should take the following actions:
- Discontinue use of the UHI-4 until the root cause investigation is completed
- Devices should be quarantined and marked appropriately by your site to prevent usage
- If your facility does not have alternatives or is unable to obtain alternatives, you may choose to use the UHI-4 while exercising extreme caution, after weighing the potential benefits of the procedure versus the potential risk to the health of over-insufflation.
- If your organisation determines option 3, please ensure staff are made aware of Pages 2 and 3 of the Field Safety Notice CONSIDERATIONS FOR PROVISIONAL USAGE and is applied in addition to patient procedure risk assessment.
- Olympus requests that you report complaints, including any injuries associated with over-insufflation during the procedure with UHI-4, to Olympus.
- Please report complaints to concerns@olympus.co.uk
- If you require additional information, please do not hesitate to contact the supplier at ra@olympus.co.uk
- If you have any further questions, please contact your local NHS Supply Chain Hospital Care team.